Engineering an Optimal Y280-Lineage H9N2 Vaccine Strain by Tuning PB2 Activity
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24108840 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Se-Hee An und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Avian Diseases, College of Veterinary Medicine and BK21 PLUS for Veterinary Science, Seoul National University, Seoul 08826, Republic o…. Hauptthemen laut MEDLINE: Influenza A Virus, H9N2 Subtype, Influenza A Virus, H5N1 Subtype, Influenza A Virus, H7N9 Subtype, Influenza in Birds. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: GeNiner Ltd., Research Institute of Veterinary Science of Seoul National University, Ministry of Health & Welfare.
Abstract (Originalsprache)
H9N2 avian influenza A viruses (AIVs) cause economic losses in the poultry industry and provide internal genomic segments for the evolution of H5N1 and H7N9 AIVs into more detrimental strains for poultry and humans. In addition to the endemic Y439/Korea-lineage H9N2 viruses, the Y280-lineage spread to Korea since 2020. Conventional recombinant H9N2 vaccine strains, which bear mammalian pathogenic internal genomes of the PR8 strain, are pathogenic in BALB/c mice. To reduce the mammalian pathogenicity of the vaccine strains, the PR8 PB2 was replaced with the non-pathogenic and highly productive PB2 of the H9N2 vaccine strain 01310CE20. However, the 01310CE20 PB2 did not coordinate well with the hemagglutinin (HA) and neuraminidase (NA) of the Korean Y280-lineage strain, resulting in a 10-fold lower virus titer compared to the PR8 PB2. To increase the virus titer, the 01310CE20 PB2 was mutated (I66M-I109V-I133V) to enhance the polymerase trimer integrity with PB1 and PA, which restored the decreased virus titer without causing mouse pathogenicity. The reverse mutation (L226Q) of HA, which was believed to decrease mammalian pathogenicity by reducing mammalian receptor affinity, was verified to increase mouse pathogenicity and change antigenicity. The monovalent Y280-lineage oil emulsion vaccine produced high antibody titers for homologous antigens but undetectable titers for heterologous (Y439/Korea-lineage) antigens. However, this defect was corrected by the bivalent vaccine. Therefore, the balance of polymerase and HA/NA activities can be achieved by fine-tuning PB2 activity, and a bivalent vaccine may be more effective in controlling concurrent H9N2 viruses with different antigenicities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Avian Diseases, College of Veterinary Medicine and BK21 PLUS for Veterinary Science, Seoul National University, Seoul 08826, Republic of Korea.
- Research Institute for Veterinary Science, College of Veterinary Medicine, Seoul National University, Seoul 08826, Republic of Korea.
- Department of Microbiology, School of Medicine, Kyungpook National University, Daegu 41566, Republic of Korea.
- Laboratory of Poultry Medicine, Department of Farm Animal Medicine, College of Veterinary Medicine and BK21 PLUS for Veterinary Science, Seoul National University, Seoul 88026, Republic of Korea.
- Farm Animal Clinical Training and Research Center (FACTRC), GBST, Seoul National University, Pyeongchang 25354, Republic of Korea.
- GeNiner Ltd., Seoul 08826, Republic of Korea.
ORCID-Profile: Chung-Young Lee, Kang-Seuk Choi, Hyuk-Joon Kwon
Förderung
- GeNiner Ltd.
- Research Institute of Veterinary Science of Seoul National University
- Ministry of Health & Welfare
Zitieren
APA
An, S. H., Hong, S. M., Song, J. H., Son, S. E., Lee, C. Y., Choi, K. S., & Kwon, H. J. (2023). Engineering an Optimal Y280-Lineage H9N2 Vaccine Strain by Tuning PB2 Activity. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24108840
Vancouver
An SH, Hong SM, Song JH, Son SE, Lee CY, Choi KS, et al. Engineering an Optimal Y280-Lineage H9N2 Vaccine Strain by Tuning PB2 Activity. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24108840
BibTeX
@article{An2023,
author = {An, Se-Hee and Hong, Seung-Min and Song, Jin-Ha and Son, Seung-Eun and Lee, Chung-Young and Choi, Kang-Seuk and Kwon, Hyuk-Joon},
title = {Engineering an Optimal Y280-Lineage H9N2 Vaccine Strain by Tuning PB2 Activity},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24108840}
}
EUVIMED